|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
8.590 +0.090 (+1.059%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 1,268,549 | 13.296% | 1,119,679 | 993,528 | 886,526 | 765,856 |
| Cost of Sales | (321,026) | 13.331% | (283,263) | (255,437) | (225,286) | (194,266) |
| Gross Profit | 947,523 | 13.284% | 836,416 | 738,091 | 661,240 | 571,590 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 433,958 | 14.924% | 377,605 | 309,517 | 307,691 | 245,917 | |
| Taxation | (32,998) | 10.825% | (29,775) | (13,877) | (62,785) | (48,703) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (1,195) | -- | 64 | 1,089 | 5,738 | 11,672 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 399,765 | 14.910% | 347,894 | 296,729 | 250,644 | 208,886 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (30,131) | 19.373% | (25,241) | (19,482) | (15,411) | (5,773) |
| Depreciation & Amortisation | 37,427 | -3.232% | 38,677 | 39,393 | 36,106 | 36,143 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 49.870 | 13.135% | 44.080 | 37.430 | 31.320 | 25.270 |
| DPS (cts) | 27.466 | -- | 13.755 | 0.000 | 8.317 | 7.142 |
| Dividend Payout Ratio (%) | 55.075% | -- | 31.205% | -- | 26.554% | 28.264% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.383 | -- | 4.068 | 3.419 | 2.872 | 2.399 |
| Remarks: | Real time quote last updated: 19/11/2024 10:08 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 399,765 |
| %Change | 14.910% |
| EPS / (LPS) | RMB 0.499 |
| NBV Per Share (¥) | RMB 4.383 |